Press Releases

Sensilab site near Lódz
Wörwag Pharma acquires production company in Poland
Böblingen/Lódz – German pharmaceutical company Wörwag Pharma GmbH & Co. KG announces the acquisition of Sensilab, contract manufacturer and development service provider of pharmaceuticals, in Lódz, Poland. For the first time in the 50-year history, the family-owned company is investing in its own production facility - a decisive milestone for future growth.
Lucia Cinque
Lucia Cinque appointed additional managing director
Wörwag Pharma announces that Lucia Cinque will join the company as Managing Director on June 1, 2021. In the newly created role of Chief Innovation Officer (CINO), she will lead the company together with Jochen Schlindwein, CEO, and Gerhard Mayer, CFO.
Positive development worldwide - Woerwag Pharma invests in the future
Despite the challenges of the Corona year, the family-owned company Woerwag Pharma successfully closes 2020 with a year-on-year increase in sales to 235.8 million euros. Despite Corona, the signs are set for investment and growth.
research
Invitation for Submissions for the Fritz-Wörwag Research Prize 2021
In order to support research and science in the field of biofactors Wörwag Pharma announces the 10th Fritz-Wörwag Research Prize.
Monika Wörwag
Change in management
After almost twenty years at the head of Woerwag Pharma GmbH & Co. KG, Monika Woerwag will step down from the management board effective on January 1, 2021. However, she will remain with the company in a management position.
Monika Wörwag
Topping-out ceremony with a difference: New company building of Wörwag Pharma
Rather than holding a topping-out ceremony, in view of the corona restrictions the management of Wörwag Pharma has decided to show its employees in Böblingen the shell of the building in group tours.
Positive development worldwide: Wörwag Pharma increases its sales in 2019
With an increase in sales of 11 percent as compared to the previous year to 234.1 million euros, Wörwag Pharma, the family-owned company from Böblingen, has also brought 2019 to a successful end.
Jochen Schlindwein
Jochen Schlindwein becomes new Managing Director
Following the departure of Dr. Marcus Wörwag from the management of Wörwag Pharma GmbH & Co. KG, Mr. Jochen Schlindwein will assume management as Managing Director and CEO, starting on December 1, 2019. He will manage the business operations of the Wörwag group together with Mr. Gerhard Mayer, Managing Director and CFO.

Press Contact

Kerstin Imbery-Will
Kerstin Imbery-WillPublic relations+49 4183 774623kerstin.imbery-will@woerwagpharma.com
Tanja Thoma-Ly
Tanja Thoma-LyCompany Communications+49 7031 6204 – 338tanja.thoma-ly@woerwagpharma.com